Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

AARP Medicare Rx “Reserve” Proposal Seeks To Bypass Cost Debate

Mar 04 2002

• By The Pink Sheet

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

Related Content

Prilosec OTC Launch By July 2002 Predicted By P&amp;G's Lafley

Jun 18 2001

Wyeth Enbrel Facility On Track For Third Quarter '02; CHF Research Dropped

May 21 2001

Wyeth Protonix I.V. Indicated As Second-Line Therapy After Oral Pantoprazole

Mar 26 2001

NPC Study Says New Drugs Offset Nondrug Spending: Will CBO Agree?

Sep 24 2001

Triclosan Antiseptic Category I Status Requested By CIBA

Sep 24 2001

HHS Lacks Authority To Create Medicare Rx Discount Card Plan, Judge Rules

Sep 10 2001

Medicare PBM Formulary Standards Set By Drug Cmte. Under Graham Bill

Jul 09 2001

Genentech Will Market OSI Cancer Drug In U.S. Under Three-Way Deal

Jan 15 2001

BASF/Takeda

Aug 28 2000

Vitamin Price-Fixing $242 Mil. Class Settlement Fund Approved

Apr 03 2000

Dilantin, Zosyn In Tight Supply As Puerto Rico Production Recovers

Dec 07 1998

Novartis Consumer Health Reshuffled, Functional Foods On Sales Block

Feb 11 2002

Triclosan Efficacy Studies Support “Significant” Antimicrobial Effect – Ciba

Feb 25 2002

Accutane Generics Need Separate Risk Management Programs, Roche Says

Feb 18 2002

Acetaminophen Toxicity Headed To NDAC, New FDA Drug Safety Group

Feb 18 2002

Schering-Plough Clarinex Gains Indication Parity With Pfizer’s Zyrtec

Feb 18 2002

Accutane Labeling Revised To Include Psychiatric Disorder Brochure

Feb 25 2002

White House Asks For More FDA Candidates As Wood Is Shed

Feb 25 2002

Medicare Disease Management Demonstration To Have Control Group Design

Feb 25 2002

Immunex Enbrel Psoriatic Arthritis 12-Month Data To Follow sBLA Approval

Jan 21 2002

Nicotine-Replacement Therapy Use By Young Smokers Urged By Researchers

Dec 24 2001

Ariva Tobacco Lozenges Outside FDA Purview, Marketer Maintains

Dec 24 2001

Merck COX-2 Cardiovascular Safety Studies Will Enroll 30,000 Subjects

Dec 17 2001

Roche Tries Genentech Formula In Japan: Chugai Deal Follows 1990 Model

Dec 17 2001

Bioterrorism Preparedness Addressed On Capitol Hill, At FDA

Dec 17 2001

RA Remission Claim May Be Granted Despite Relapse - FDA Guidance

Feb 22 1999

Healthcare Reform Returns To Political Agenda Heading Into 2002 Elections

Jan 21 2002

Schering-Plough Clarinex Launch Strategy Follows Nexium Model

Jan 07 2002

Cargill poised to become "major supplier" of supplement ingredients, firm predicts.

Mar 23 1998

BMS Streamlining To Focus On Consumer Medicines, Nutritionals

Oct 02 2000

White House Wants To “Manage” Expectations For Medicare Rx

Feb 18 2002

Vaccine Manufacturing Data Could Be Shared To Prevent Shortages – Aventis

Feb 18 2002

Allegra Growth Expected At 20% Annually; Generic Impact Possible In 2004

Feb 18 2002

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window